论文部分内容阅读
原发性扩张型心肌病是一组原因不明的以心脏扩大和心肌收缩功能减退为主要特征的心脏病,预后不佳,且缺乏有效的治疗措施.现将我院自1990年以来应用美托洛尔治疗扩张型心肌病(DCM)的疗效报道如下.1 材料和方法1.1 对象 本组20例,男14例,女6例;年龄22～63岁,平均38.4岁.均为住院患者.心功能(NYHA标准)Ⅲ级8例,Ⅵ级12例.全部病例均符合以下诊断标准:①心脏增大及心力衰竭的临床表现;②超声心动图示心脏各房室明显扩张,空间隔及室壁运动幅度普遍减低,二尖瓣开放幅度变小;③除外其它心脏病及特异性心肌病.1.2 方法 本组患者均经卧床休息、限盐及吸氧,常规应用洋地黄及利尿剂等治疗2周以上,病情不缓解或加
Primary dilated cardiomyopathy is a group of unknown causes of heart enlargement and myocardial systolic dysfunction as the main feature of heart disease, the prognosis is poor, and the lack of effective treatment measures now our hospital since 1990, the United States care The efficacy of lol’s treatment of dilated cardiomyopathy (DCM) reported as follows.1 Materials and Methods 1.1 Object The group of 20 patients, 14 males and 6 females; aged 22 to 63 years, mean 38.4 years of age were hospitalized patients heart The function (NYHA standard) grade Ⅲ in 8 cases, grade Ⅵ in 12. All cases were in line with the following diagnostic criteria: ① heart increased and clinical manifestations of heart failure; ② echocardiography showed a significant expansion of the heart atrioventricular compartment and space compartment Wall motion amplitude generally reduced, mitral valve opening amplitude smaller; ③ except for other heart disease and specific cardiomyopathy .1.2 Methods The patients were bed rest, salt and oxygen, routine use of digitalis and diuretics and other treatment 2 weeks or more, the disease does not ease or increase